One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood.v126.23.138.138
Copy DOI Journal: Blood |  Publication Date: Dec 3, 2015 |
 Citations: 22 |
Affiliation: Cardiff University, Hospital Universitario de La Princesa, Jena University Hospital, University of Michigan–Ann Arbor, University of Adelaide, Oregon Health & Science University, Seoul St. Mary's Hospital, Novartis (United States), Sapienza University of Rome, Kobe University, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Singapore General HospitalABL001, a Potent, Allosteric Inhibitor of BCR-ABL, Exhibits Safety and Promising Single- Agent Activity in a Phase I Study of Patients with CML with Failure of Prior TKI Therapy
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
